Tau PET imaging in neurodegenerative tauopathies—still a challenge

A Leuzy, K Chiotis, L Lemoine, PG Gillberg… - Molecular …, 2019 - nature.com
The accumulation of pathological misfolded tau is a feature common to a collective of
neurodegenerative disorders known as tauopathies, of which Alzheimer's disease (AD) is …

A walk through tau therapeutic strategies

S Jadhav, J Avila, M Schöll, GG Kovacs… - Acta neuropathologica …, 2019 - Springer
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …

Four distinct trajectories of tau deposition identified in Alzheimer's disease

JW Vogel, AL Young, NP Oxtoby, R Smith… - Nature medicine, 2021 - nature.com
Alzheimer's disease (AD) is characterized by the spread of tau pathology throughout the
cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals …

Regional Aβ-tau interactions promote onset and acceleration of Alzheimer's disease tau spreading

WJ Lee, JA Brown, HR Kim, R La Joie, H Cho, CH Lyoo… - Neuron, 2022 - cell.com
Amyloid-beta and tau are key molecules in the pathogenesis of Alzheimer's disease, but it
remains unclear how these proteins interact to promote disease. Here, by combining cross …

Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

JW Vogel, Y Iturria-Medina, OT Strandberg… - Nature …, 2020 - nature.com
Tau is a hallmark pathology of Alzheimer's disease, and animal models have suggested that
tau spreads from cell to cell through neuronal connections, facilitated by β-amyloid (A β). We …

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease

N Franzmeier, J Neitzel, A Rubinski, R Smith… - Nature …, 2020 - nature.com
In Alzheimer's diseases (AD), tau pathology is strongly associated with cognitive decline.
Preclinical evidence suggests that tau spreads across connected neurons in an activity …

The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography

JS Sanchez, JA Becker, HIL Jacobs… - Science translational …, 2021 - science.org
Advances in molecular positron emission tomography (PET) have enabled anatomic
tracking of brain pathology in longitudinal studies of normal aging and dementia, including …

High-contrast in vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer's disease tauopathies

K Tagai, M Ono, M Kubota, S Kitamura, K Takahata… - Neuron, 2021 - cell.com
A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal …

Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models

MC Silva, FM Ferguson, Q Cai, KA Donovan, G Nandi… - elife, 2019 - elifesciences.org
Tauopathies are neurodegenerative diseases characterized by aberrant forms of tau protein
accumulation leading to neuronal death in focal brain areas. Positron emission tomography …

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease

N Franzmeier, A Dewenter, L Frontzkowski… - Science …, 2020 - science.org
In Alzheimer's disease (AD), the Braak staging scheme suggests a stereotypical tau
spreading pattern that does, however, not capture interindividual variability in tau deposition …